<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
XGN
Exagen
$
()


  • What You Missed On Wall Street On Monday

    3/18/2024 - 16:23pm
  • Exagen continues to execute on re-acceleration strategy, says Canaccord

    3/18/2024 - 13:49pm
  • What You Missed On Wall Street This Morning

    3/18/2024 - 12:05pm
  • Exagen sees FY24 revenue $54M, consensus $54.13M

    3/18/2024 - 08:03am
  • Exagen reports Q4 EPS (31c), consensus (43c)

    3/18/2024 - 08:02am
  • Exagen reaffirms FY23 revenue of at least $50M, consensus $50.43M

    1/7/2024 - 13:58pm
  • Exagen files $150M mixed securities shelf

    11/17/2023 - 16:08pm
  • Exagen sees FY23 revenue at least $50M, consensus $46.76M

    11/13/2023 - 16:13pm
  • Exagen reports Q3 EPS (31c), consensus (47c)

    11/13/2023 - 16:13pm
  • Exagen management to meet virtually with BTIG

    9/21/2023 - 04:55am
  • Exagen management to meet virtually with BTIG

    9/18/2023 - 12:12pm
  • Exagen sees Q3 revenue $10M-$10.5M, consensus $11.76M

    8/7/2023 - 08:04am
  • Exagen reports Q2 EPS (28c), consensus (49c)

    8/7/2023 - 08:03am
  • Exagen reports Q1 EPS (44c), consensus (56c)

    5/15/2023 - 16:25pm
dynamic_feed Breaking News